Meet The UK Doctor Who Tried To Defy The FDA's Approval Of A New Opioid

Nov 14, 2018

The US Food and Drug Administration recently gave its approval of a new drug called Dsuvia, an opioid five to 10 times more potent than fentanyl and 500 times more powerful than morphine.  The FDA green lighted the opioid over the objections of a local physician who chairs its advisory committee.  Dr. Raeford Brown is the guest this week on Dr. Greg Davis on Medicine.

This undated image provided by AcelRx Pharmaceuticals shows the dispenser and a tablet for the company's medication Dsuvia. On Friday, Nov. 2. 2018, U.S. regulators announced the approval of the fast-acting, super-potent opioid tablet as an alternative to IV painkillers used in hospitals. (Craig Sherod Photography/AcelRx Pharmaceuticals via AP)

Dr. Brown is professor of Anesthesiology and Pediatrics at UK Healthcare, and the Chair of the FDA Advisory Committee on Anesthetic and Analgesic Drug Products.  He defied the official opinion of that panel, which recommended approval of the drug.  Brown told our Dr. Davis that he thinks it’s reckless and wrong to make a new opioid available now – at a time when so many communities are dealing with an opioid crisis.

Read more about the controversy here: